Yan-fang Liu

Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology

Lili Yan, Zhen Zhang, Yan-fang Liu, 2022, Frontiers in Molecular Biosciences.

A Phase I clinical trial of chimeric antigen receptor-modified T cells in patients with relapsed and refractory lymphoma.

Hongling Zhang, Yan-fang Liu, YOUHAI H. Chen, 2020, Immunotherapy.

Long-term clinical efficacy of cytokine-induced killer cell-based immunotherapy in early-stage esophageal squamous cell carcinoma.

Yan-fang Liu, Yi Zhang, Guohui Qin, 2022, Cytotherapy.

Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy

Hongling Zhang, Yan-fang Liu, Y. Qiao, 2018, Journal of immunotherapy.